These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29474707)

  • 41. DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitis.
    Arora N; Caldwell A; Wafa K; Szczesniak A; Caldwell M; Al-Banna N; Sharawy N; Islam S; Zhou J; Holbein BE; Kelly MEM; Lehmann C
    Clin Hemorheol Microcirc; 2018; 69(1-2):153-164. PubMed ID: 29630535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of cytokines in ocular inflammation].
    Rusiecka-Ziółkowska J; Misiuk-Hojło M
    Przegl Lek; 1997; 54(12):863-6. PubMed ID: 9591456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ocular Sarcoidosis.
    Pasadhika S; Rosenbaum JT
    Clin Chest Med; 2015 Dec; 36(4):669-83. PubMed ID: 26593141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunomodulatory therapy for anterior segment ocular inflammation.
    Reed MD; Chu DS
    Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):429-33. PubMed ID: 12582328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ocular mast cells and mediators.
    Irani AM
    Immunol Allergy Clin North Am; 2008 Feb; 28(1):25-42, v. PubMed ID: 18282544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of chemokines in ocular diseases. Part II. Participation of chemokines in ocular diseases].
    Malesiński R; Mrugacz M; Bakunowicz-Łazarczyk A
    Klin Oczna; 2007; 109(7-9):345-8. PubMed ID: 18260295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The link between morphology and complement in ocular disease.
    Mohlin C; Sandholm K; Ekdahl KN; Nilsson B
    Mol Immunol; 2017 Sep; 89():84-99. PubMed ID: 28622910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mucosal immune tolerance at the ocular surface in health and disease.
    Galletti JG; Guzmán M; Giordano MN
    Immunology; 2017 Apr; 150(4):397-407. PubMed ID: 28108991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Family studies of ocular manifestations in arthritis.
    Saari M; Vuorre I; Kaila J; Lahti R
    Can J Ophthalmol; 1978 Jul; 13(3):144-51. PubMed ID: 698885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dendritic cell physiology and function in the eye.
    Forrester JV; Xu H; Kuffová L; Dick AD; McMenamin PG
    Immunol Rev; 2010 Mar; 234(1):282-304. PubMed ID: 20193026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis.
    De Majumdar S; Subinya M; Korward J; Pettigrew A; Scherer D; Xu H
    Curr Mol Med; 2017; 17(3):211-220. PubMed ID: 28782485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.
    Thorne JE; Woreta F; Kedhar SR; Dunn JP; Jabs DA
    Am J Ophthalmol; 2007 May; 143(5):840-846. PubMed ID: 17362866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endotoxin-induced uveitis in rodents.
    Yadav UC; Ramana KV
    Methods Mol Biol; 2013; 1031():155-62. PubMed ID: 23824898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Uveitis immunopathology: currents knowledge, clinical correlation and research perspectives in the immue-ocular area].
    Jiménez Martínez MC; Carrera I; Pedroza Seres M; Jaimes M; Schlaen A; Garfias Y
    Rev Alerg Mex; 2006; 53(6):226-35. PubMed ID: 17361757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of the immune system in uveitis induced in animals.
    Hylkema HA
    Doc Ophthalmol; 1988 Dec; 70(4):339-51. PubMed ID: 3075176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease.
    Chang JH; McCluskey PJ; Wakefield D
    Br J Ophthalmol; 2006 Jan; 90(1):103-8. PubMed ID: 16361678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitric oxide and peroxynitrite production in ocular inflammation.
    Allen JB; Keng T; Privalle C
    Environ Health Perspect; 1998 Oct; 106 Suppl 5(Suppl 5):1145-9. PubMed ID: 9788889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic treatment with glutathione PEGylated liposomal methylprednisolone (2B3-201) improves therapeutic efficacy in a model of ocular inflammation.
    Reijerkerk A; Appeldoorn CC; Rip J; de Boer M; Gaillard PJ
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2788-94. PubMed ID: 24692123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of cytokines in the pathogenesis of inflammatory eye disease.
    Wakefield D; Lloyd A
    Cytokine; 1992 Jan; 4(1):1-5. PubMed ID: 1617154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.